Local warehouses. Local dispatch. Australia · Canada · USA
Peptide names explained

Epitalon vs Epithalon.
Two spellings. Check one identity.

Follow the name back to the peptide sequence, then compare the research and catalogue content on the same basis.

Epitalon and Epithalon are names used for the AEDG tetrapeptide in the scientific literature. The National Library of Medicine’s MeSH record lists both as entry terms for alanyl-glutamyl-aspartyl-glycine. It also includes the spelling Epithalone. See the NLM identity record.

This is a naming question, rather than a competition between two catalogue products. Aurelis uses Epitalon for its 10 mg listing. When a paper or document uses another spelling, match the sequence and specification before treating the records as equivalent.

Epitalon vs Epithalon at a glance

Names, research identity and Aurelis catalogue content
TermWhat it identifiesWhat to check
EpitalonA name used for Ala-Glu-Asp-Gly in a 2020 primary studyComplete identity in the paper and batch documents
EpithalonAn entry term in the same NLM substance recordSequence and specified chemical form, rather than spelling alone
AEDGOne-letter sequence for alanine, glutamate, aspartate and glycineOrder of the four residues
Aurelis Epitalon 10 mgListed content per unitAmount basis and available presentation

What does AEDG mean?

AEDG describes the four amino-acid residues in order: A for alanine, E for glutamate, D for aspartate and G for glycine. The three-letter form is Ala-Glu-Asp-Gly. A tetrapeptide contains four residues; the name does not refer to a four-product blend.

The 2020 Khavinson and colleagues paper explicitly identifies its experimental peptide as AEDG, Ala-Glu-Asp-Gly, Epitalon. That makes it a useful primary reference for connecting the abbreviation with the longer name. Read the primary AEDG study.

A sequence is a starting point for matching documents, not a substitute for the complete material specification. Preserve any stated chemical form, modifications and reporting basis. If two records disagree, ask for clarification rather than deciding that a similar name makes the difference unimportant.

Why does this name appear in cellular-ageing research?

A 2003 study published under the spelling Epithalon examined human fetal fibroblast cultures. The researchers reported telomerase activity and telomere elongation after adding the peptide. Telomeres are structures at chromosome ends; telomerase is an enzyme involved in maintaining them. Read the original cell-culture study.

The study setting matters: these were cells in culture, not a test of the Aurelis catalogue material or a measurement of human lifespan. Keep the experimental model and measured endpoint beside the finding when comparing papers. The Epitalon profile introduces this cellular research context.

The 2020 study asked a different question. It examined neurogenic differentiation markers in human gingival mesenchymal stem cells and reported changes in marker expression and synthesis. Read the study abstract and experimental context. Different endpoints can appear under the same peptide name; they should not be combined into a single promised outcome.

Epitalon 10 mg: content, not concentration

The current Aurelis catalogue lists Epitalon 10 mg per unit. This identifies a listed amount. It does not define a liquid volume, a concentration, an amount delivered by a device or a use schedule.

For a comparison, place the name, amount and presentation in separate fields. An entry with the same spelling but a different amount is a different catalogue specification. An entry with another spelling needs an identity match before its amount becomes a meaningful comparison.

Ask for the selected batch’s identity and content records through our quality-documentation page. A literature reference establishes what that paper studied; a batch record identifies what is being offered.

Keep the format alongside the specification

Aurelis presents both vials and pen-style kits. Confirm which configuration is available for the named entry. A product rendering is a presentation illustration, rather than a complete component or formulation record.

For a named blend, retain the accepted component list and each stated amount. Do not add Epitalon to a blend because the blend sits in an ageing category. Our blend guide preserves listed details and unresolved specifications.

Make an enquiry that can be answered precisely

Send Epitalon, 10 mg listed content, preferred presentation and destination in the USA, Canada or Australia. If your source uses Epithalon, include that spelling and the AEDG reference too. Request the matching specification and batch records, plus confirmation of current local availability.

Enquire about Epitalon or email sales@aurelispeptides.com. Explore the research library for comparisons of other catalogue names.

Sources

  1. NLM MeSH · alanyl-glutamyl-aspartyl-glycine — name mapping.
  2. Khavinson et al. · Molecules · 2020 — AEDG identity and stem-cell experiment.
  3. Khavinson et al. · Bulletin of Experimental Biology and Medicine · 2003 — telomerase experiment in fibroblast cultures.

Connect with Aurelis

Your next enquiry
starts with the details.

Tell us the compound, listed content, preferred presentation and destination. Our team can discuss local availability and the documentation for your selected material.